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AN ABSTRACT OF A MASTER'S THESIS
ABSTRACT
As plasma membrane components of many cells, gangliosides have
been shown to serve as membrane receptors for various biologically
active substances. Furthermore, gangliosides have been
demonstrated to modulate the effects o-f various growth factors.
Even though gangliosides are capable of modulating the effects of
growth factors such as platelet-derived growth factor and
epidermal growth factor, they do not bind to these
growth-affecting molecules. We have examined the interaction of
gangliosides with molecules which inhibit the growth of cultured
an imal cells.
Growth-inhibitory gl ycopep t i des have been purified and
characterized from bovine cerebral cortex cells. These
glycopepti des are capable of inhibiting both protein synthesis and
cell division in normal cells. Mouse LM cells have no detectable
gangl i osi des wi thin their plasma membranes and are refractory to
the inhibitor. Incubation of e«ogenous GM gangliosides with the
1
LM cells confers sensitivity to the inhibitor upon the cells. The
sensitization of cells to the inhibitory action of the
glycopepti des implies that GM may act as a membrane receptor or
1
receptor modulator for these molecules. Elucidation of the
functional role played by GM in this growth-regulatory process
1
was analyzed by both In uauo and ±n uXtca 1 i gand-recep tor binding
assays to detect binding of inhibitor to gangliosides. In cell
binding assays, it was shown that incubation of exogenous
gangl iosides wi th these cells, though capable of sensitizing them
to the growth inhibitor, did not result in an increase in binding
of the inhibitor to the cells. Furthermore, various ±n uj.±z:o
1 i gand-recep tor binding assays were performed using the cholera
toxin-GM ligand receptor model. These studies also demonstrated
the inability of the growth inhibitor to bind to GM
gangl i osi des. In addition, protease digestion of cells able to
bind the growth inhibitor significantly decreased inhibitor
binding. This implies that a membrane protein was involved in the
growth inhibitor-membrane interaction. Neuraminidase treatment o-f
the same cells was able to enhance slightly the binding of the
growth-inhibitory gl ycopep t i des to the cells apparently from an
increase in membrane GM
. These data sugoest that membrane
1
gangl ioside GM functions in the modulation of the actual membrane
1
receptor for the growth inhibitory gl ycopep t i des
.
Hypotheses explaining the molecular mechanism of GM as a
1
modulator of membrane receptor(s) are speculative at best.
Progress in the elucidation of the role of gangl i o i s i des as
membrane receptors has been achieved through studies of the
interaction of the enterotoxir, of Uj.bxj.,0 dtalACAa with the GM
1
gangl ioside. As a lectin-like molecule, cholera toxin has proved
to be a useful investigative tool towards the understanding of
membrane structure and receptor mobility as well as receptor
function. GM gangl ioside has been demonstrated to be freely
mobile within the lipid bilayer. Thus, GM is capable of
1
interacting with other membrane components such as membrane
proteins (receptors) and lipids. Specifically, when GM is
1
incorporated into model membrane lipid systems, the interaction of
GM w,th the phosphol ipid<s) results in an increase in membrane
order. We examined the effect* of 1 i gand-recep tor interaction
between GM and cholera toxin to elucidate the functional and
behavioral role of GM as a membrane receptor. By employing
fluorescence polarization and light scattering, we were able to
detect lectin-induced agglutination of liposomes containing GM .
In addition, glycolipid clustering events within these model
membranes resulted in a disordering of the membrane lipids. Such
events can significantly alter membrane dynamics which in turn can
lead to changes in membrane permeability or cell surface
f unc t i on
.
Chapter I .
LITERATURE REVIEW
INTRODUCTON
I. MOLECULAR MEMBRANE BIOLOGY
Biological membranes are organized assemblies consisting mainly
of lipids and proteins. Membranes act as highly selective
permeability barriers containing specific molecular pumps and
gates. In addition, membranes give cells their individuality by
separating them -from their environment. Membranes serve to
control the social interactions between cells and between cells
and various biologically active substances in the cell's
environment by specific membrane receptors. These receptors
receive external stimuli as well as generating chemical or
electrical signals -for cell-to-cell communication.
Due to the immense diversity ot protein and lipid molecules
within intact plasma membranes, assignment of biological
-function
to their various components would be an insurmountable task. To
simplify the problem, model lipid or reconstituted membrane
systems of known lipid and protein composition are employed. Data
obtained from such analyses permit definition and assignment of
function to the particular membrane constituents.
The current working hypothesis of ceil membrane structure is the
fluid mosaic model popularized by Singer and Nicholson ( 1 :>
,
whereby both protein and lipid are dynamic in nature. Moreover,
the fluidity, flexibility, and general physical properties of the
plasma membrane are determined by the chemical composition and
- 2 -
physical state of the lipid(s) present. For example, lipids
undergo thermal phase transitions, called gel-liquid crystalline
transitions, in which the acyl chains of the lipids change from
ordered and rigid to disordered and -fluid (2,3;. This lipid
fluidity imparted membranes by lipids has been demonstrated to
perform a functional role in several membrane processes such as
membrane transport (4,5); activity of membrane bound proteins (6);
intercellular communication (7); cellular development (8) ) and
cellular trans-formation (9,10).
The mobility o-f membrane components has been examined by various
techniques. Physical methods which involve the introduction of a
molecular probe into the membrane include: nuclear magnetic
resonance (NMR) (11, 12); electron spin resonance (ESR) (13,14);
differential scanning calorimetry (DSC) (15): and fluorescent
polarization (16,17), (for reviews, 18-22). All have advantages
and disadvantages. The greatest disadvantage o-f these
spectroscopic techniques is the perturbation of the membrane
induced by the probe (16,17).
In the studies described below, we used a pair of linear polyene
fatt>- acid probes 9, 11 , 13,13-cx*» leans.,. icias^
CLS-oc tadecate traenoi c acid and its a 1 1 -leans, isomer, 9, 11, 13,
15-al 1 -lca.as.-oc tadecate traenoi c acid (cis-par i nar i c acid and
icaas-par i nar i c acid, respectively) (See -figure 1). These two
probes were developed and defined spec troscop i cal 1 y as to
orientation and location within the plasma membrane by Sklar, e_±
Al . (23). These two isomers absorb and -fluoresce in unique
spectral regions (290-325 nanometers and 420 nanometers,
respectively) and as such, their -fluorescence is not obscured by
intrinsic chromophores such as the aromatic amino acids and
porphyrins (23, 24). Cis-, and ±.r_aas.-par i nar i c acid (cxa-PnA and
ica.as.-PnA, respectively) when incorporated into the membrane are
linear and similar enough to naturally occurring components that
the degree o-f perturbation is minimal. Cis-PnA inserts into the
membrane and exhibits no preference -for solid or liquid state o-f
the lipids. However, trans-PnA when incorporated into the
membrane prefers solid phase lipids. Furthermore, the perturbing
influences these semi-intrinsic probes are minimal relative to
other fluorescent probes (23, 24).
Due to their amphiphatic nature, phospholipids will
spontaneously reassociate in an aqueous environment to form
bi layers. This self assembly makes biophysical studies on
membrane mobility possible (25). The distribution and asymmetry
displayed by the phospholipids in a liposome are dependent upon
the thermodynamic stability of the constituents (25, 26). Thus,
the distribution of phosphol
i
p i ds w i th i n a liposome are dependent
upon the size of the headgroup, and the packing (degree of
unsaturat i on) of the fatty acid acyl chains (26).
II. THE STRUCTURE AND FUNCTION OF MEMBRANE SANGLIOSIDE
Of the major membrane components, glycol ipids, and in
particular, gang! i os i des, have been shown to interact with various
biologically active factors such as, bacterial toxins (?, 27-32);
glycoprotein hormones (33-38); viruses (39-41); interferon (39,
41); and possibily growth regulatory gl ycopep t i des (42-44). On the
basis of these data, one possible
-function of membrane
gangliosides is to serve as membrane receptors or modulators at
other membrane receptors within the plasma membrane. Gangliosides
have also been shown to play a role in cellular interactions and
differentiation, in cell growth control (oncogenic
transformation), and in immune recognition (10). However, the
molecular details of ganglioside functions are still speculative
due to the lack of information on their organization within the
plasma membrane and their surface properties (45).
Gangliosides are amphipathic containing both hydrophobic and
hydrophilic regions. They comprise a family of negatively charged
acidic glycol i p i ds that are characterized by the presence of at
least one sialic acid residue (N-ace tyl neuram i na te or
tJ-glycolylneuraminate)
. It has been speculated that the negative
charge conferred upon the molecule by the sialic acid is important
in their function as cell surface receptors for soluble ligands
and cellular components. In all gangliosides, one sialic acid is
linked to the 3-position of a galactose residue (47). The
structure of the common ganglioside species, monos i al ogangl i osi de
CGM ) is illustrated in figure 2. GM has a five sugar
1
1
oligosaccharide containing a single sialic acid resiude. This
- 5 -
hydrophilic head group, which protrudes into the extracellular
environment is linked to the hydrophobic sphingosine portion of
the ceramide. The carbohydrate side-chain is synthesized via
stepwise addition o-f sugar residues. The sugars are donated by
UDP-ac t
i
vated derivatives o-f the sugars (48).
The receptor function of membrane gangliosides is not clearly
understood. One hypothesis states that they exist as monomers
within the -fluid membrane matrix and ligand binding leads to
clustering and subsequent internalization (49-51). An alternative
scheme proposes that they initially exist as clusters and binding
o-f biologically active materials causes dispersion reclustering
elsewhere in the membrane (52). The receptor -function of membrane
gangl iosides is probably not analogous to that o-f protein
receptors; additionally, they components are probaoly not as
e-f-fective a receptor as are glycoproteins. Their receptor
function, however is best explained by the dynamic behavior o-f the
gangliosides within the outer leaflet o-f the plasma membrane. The
intrinsic mobility o-f a gangl ioside within the outer leaflet of
the plasma membrane is defined by several parameters including the
head group structure of the gangl ioside species, by the order of
the other membrane components, the concentration of a particular
gangl ioside within the membrane, and the interaction of the
ganglioside with a ligand. For ex amp 1 e , the mobi 1 i ty of a
gangl ioside might be decreased by increasing the concentration of
that molecule, an effect which may result from the aggregation of
the glycolipids. Further, 1
i
gand-i nduced mobility increases
signi f icantly at 1 ow concen trat i ons of the 1 i gand mol ecu 1 e (52,
53). However, at higher or saturating concentrations of ligand,
ganglioside mobility is greatly reduced (52-56).
Progress in elucidation o-f the role of gangliosides as membrane
receptors has been achieved by studies of the interaction of the
enterotoxin of Uitar i O cb.ole.c;a with GM (31, 57, 53). Cholera toxin
1
is an oligomer i c protein consisting of two major subgroups, A and
B with an aggregate molecular weight of 84,000 daltons. There are
five B subunits per toxin molecule and one A subunit per ~
;
molecule (59). The B subunit, or chol ergenoi d , with a molecular
weight of 15,000 per unit, is responsible for binding the toxin to
the GM membrane receptor. The A subunit is a dipeptide of 28,000
1
daltons linked by disulfide bridges. It is the A subunit which
confers biological activity upon the toxin molecules this toxicity
is dependent upon the B subunit for interaction with cell
membranes. The A subunit activates adenylate cyclase in a
reaction involving nicotinamide adenine dinucleotide (NAD). This
results in greatly enhanced levels of cyclic adenosine 3, 5-cyclic
monophosphate (cAMP) ',60, 61). The adenylate cyclase is activated
irreversibly ( 59)
.
The five subunits of B provide it with pen taval en t-1 i ke
properties. Due to the pentavalent nature of the B subunit of
cholera toxin behaves analogously to a lectin (53). Lectins are
multivalent carbohydrate-binding proteins and can be isolated from
7 -
various plants and invertebrates. Each lectin is specific for a
certain carbohydrate and because of their multivalent nature will
cause agglutination of receptor molecules by crossl inking the
surface carbohydrates of adjacent molecules (26). The same
phenomenon is also observable in liposomes (26). Thus, lectins
have a useful application for understanding membrane structure and
mobility as well as receptor function.
III. HYPOTHESES TO BE TESTED
A. DISTRIBUTION OF GANGLIOSIDES WITHIN THE PLASMA MEMBRANE—
GANGLIOSIDES EXIST AS MONOMERS IN BIOMEMBRANES
It has been demonstrated (62) that limited concentrations of
exogenous gangliosides can be incorporated into lipid bilayers.
Using these stable, GM -containing bi layer systems several
1
investigators (62,63) have been able to show that the
incorporation of GM into the lipid bi layer increases the
1
stability of the membrane. However, no single model membrane
system encompasses all the biological features of the cellular
plasma membrane.
The first data on the mobility of GM was by Riedler (64). Using
1
the technique of fluorescence photobl each i ng recovery and a
fluorescent analog of GM
,
Riedler examined the lateral mobility
1
of GM -like molecule within 3T3 mouse fibroblast plasma
1
membranes. Furthermore, he found that the GM probe was
1
unaffected by cytoskeletal poisons; by crossl inking membrane
glycoproteins with either lectin or antibodies: or by trans-forming
the -fibroblasts with 3V40
. Additional observations by Riedler
showed that cholera toxin was capable o-f patching the GM probe,
1
an effect which again was unaltered by cytoskeletal poisons.
These data imply that GM is capable o+ dif-fusing freely
1
throughout the plasma membrane and that the GM receptors do not
1
appear to be localized in discrete domains within the bilayer.
Recent work in our laboratory C3J>, using parinaric acid
fluorescent probes in unilamellar phosphatidylcholine vesicles,
has demonstrated that increasing amounts o-f GM incorporated into
1
liposomes, results in an increase in the order o-f the membrane
lipid. This stability in the membrane, induced by GM
,
is more
1
evident in phosphatidylcholine vesicles with longer and saturated
acyl chains. This has been demonstrated with both dipalmitoyl-
and dimyr i stoyl -phosphat i dyl chol i ne (DPPC and DMPC,
respectively). In phosphatidylcholine vesicles comprised o-f -fatty
acids with saturated 18-carbon acyl chains, there is a decrease in
the membrane order as compared to the shorter saturated species o-f
1 i p i d
.
The increase in membrane order observed in these i posome
systems is due to interaction between the GM ganglioside and the
1
lipid within the vesicles. GM incorporation into unilamellar
1
phosphatidylcholine CPC) vesicles induces a phase separation at
temperatures above the phase transition o-f PC vesicles alone.
This phenomenon, as detected by -fluorescence polarization, holds
9 -
for all PC vesicles independent o-f acyl chain length o-f the -fatty
acids. Further since GM exhibits no phase transition within the
1
temperature range o-f these experiments, the data imply that GM -PC
1
interaction increases membrane order.
Other studies which also suggest that sph i ngol i p i ds exist in
discrete domains came -from Lee, e.i a.1. , (52) who used gangliosides
with spin-labeled oligosaccharides to measure anistropy o-f various
GM /PC vesicles. From their data, Lee, £± jj..,<52) were able to
1
conclude that the size o-f the oligosaccharide head group played a
role in the dispersion o-f gangliosides within the phospholipid
bilayer and their dynamic state within the membrane.
All o-f these data taken together provide the compelling reasons
-for pursuing the investigation o-f the dynamic behavior o-f GM
1
within the plasma membrane. The benavior o-f 1 i gand-recep tor
interaction was analyzed as the the effects of ligand binding on
the molecular motion of the GM ganglioside within experimental
1
membranes. Specifically, the interactions o-f the ligands, cholera
toxin and peanut lectin, with di e 1 a i doy
1
phosphat i dy
1
chol i ne CDEPC)
were studied. The results of these experiments will be helpful in
elucidating both the -functional and behavioral role of GM as a
1
membrane receptor.
B. FUNCTIONAL ROLE PLAYED BY GANGLIOSIDES IN GROWTH REGULATION
— EXAMINATION OF RECEPTOR FUNCTION FOR GROWTH-INHIBITORY
GLYCOPEPTIDES
10
Gangliosides not only -function as membrane receptors for
biologically active substances and as modulators of protein and
glycoprotein membrane receptors, they have been shown to -function
in the regulation o-f cell growth and cellular interaction (10).
Dramatic changes in glycol ipid composition and metabolism
associated with oncogenic trans-formation suggest a speci-fic role
for membrane glycol i p i ds in the regulation o-f cell growth and
cellular interaction. Two general types o-f changes in ganglioside
composition o-f the plasma membrane are observed in trans-formed
cells which produce tumor-distinct glycolipids. The deletion o-f
complex gangliosides in trans-formed cells may arise -from a block
in the stepwise synthesis o-f the gangliosides leading to an
accumulation o-f precursor structures. Alternatively, these
simpler glycolipids may arise from altered activity o-f
gl ycosyl transferases which leads to the production of new
glycolipids atypical to those normally expressed in the
un transformed cell (For review, see ref. 10).
The possible role for glycolipids in cell growth control has
been investigated by various approaches. Exogenous incorporation
of gangliosides into the cellular membrane from culture media
(65-68), or addition of growth regulatory substances and growth
modulators (36-38,43, 44), or an t
i
gl ycol
i
p i d antibodies (69) have
all been utilized. These treatments are capable of greatly
affecting cell growth, behavior, morphology, and saturation
density. Typically, normal cells in the presence of gangliosides
1 1
show increased cellular adhesiveness and reduced saturation
density, whereas, trans-formed cells mimic normal cells and show
significant enhancement of glycol ipid synthesis.
Changes in glycol ipid composition have also been associated with
cellular interaction and differentiation. Studies have
demonstrated that cell contact induces enhanced glycol ipid
synthesis, thus, implicating glycol i p i ds as the basis of contact
inhibition o-f cell growth (For review, see ref. 10). It has been
proposed that oncogenesis and differentiation are related
processes in that, in each response, there is a dynamic continum
in the alterations of the composition of the cell surface
structure. Obviously, the involvement of gangliosides in these
processes is a subject of intense interest.
Recently, growth-inhibitory gl ycopep t i des have been purified and
characterized from bovine and murine cerebral cortex cells
(73-83). These brain cell surface gl ycopep t i des CBCSG) contain two
inhibitory fractions of molecular weights 12,000 and 15,000
da It on s that are capable of inhibiting the protein synthesis and
cell division in normal cells in a dose dependent manner. The
growth inhibition by these molecules occurs during protein
translation inhibiting elongation of nascent polypeptide chains.
The inhibitor is capable of exerting its effects at physiological
(ng/ml) concentrations. Inhibition is n on -lethal, reversibile,
and has not been shown to be either species or tissue specific.
Cells without membrane gangliosides or undetectable levels of the
12
GM ganglioside, remain refractory (78-82). For example, mouse LM
cells which have no detectable gangliosides within their plasma
membrane are refractory to the inhibitor. However, preincubation
of LM cells with GM ganglioside confers sensitivity to the
1
inhibitor (43). This sensitization of LM cells to the inhibitory
action of the gl ycopep t i des implies that the GM ganglioside may
1
act as a membrane receptor or serve as a modulator of the receptor
for the growth-i nh
i
btory gl ycopep t i des
.
In similar analyses, mouse 1316 fibrosarcoma cells were shown to
be refractory to the growth inhibitor (43). The unresponsive
nature of these transformed cells was associated with an absence
of the GM ganglioside detected by thin layer chromatography
1
(TLC)
.
Furthermore, TLC was employed to demonstrate the ability of
the 1316 cells to incorporate GM under appropriate conditions.
1 o
Fibrosarcoma cells preincubated at C for two hours with GM
1
incorporated the ganglioside and became sensitive to the growth
inhibitor. However, if after preincubation of 1316 cells with GM
o 1
at C the cells were returned the cells to 37 C, the cells once
again became refractory to the inhibitor. The concomitant
disappearance of GM in 1316 cells after incorporation was
1
suggested to reflect the cells' transformed phenotype.
The interaction of BCSG with the cell at the level of the plasma
membrane is required for biological activity. The possibilty
exists that the monos i al ogangl i os i de , GM , is a BCSG receptor or
1
modulator of BCSG activity. In the present study, therefore. the
- 13
elucidation of the
-functional role of GM in the sensitization o-f
1
cells to the growth-regulatory processes o-f BCSS were investigated
by employing the cholera toxin-GM 1
i
gand-recep tor system as a
1
reference model in various 1
i
gand-recep tor binding assays. These
studies enable us to discern whether the inhibitor binds to GM or
1
whether GM serves merely to modulate the -function o-f the actual
1
recep tor .
14
£j.j311C£ 1: Line drawings o-f parinaric acid probes characterized
by L. Sklar (PhD Dissertation, 1976).
A. 9, 11, 13, 1 5-cxa^. icins^. icaas^. cis- parinaric acid;
8. ?, 11, 13, 1 5-all-±cans.-par i nar i c acid.
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X
§
£-L&u.L£ 2: Structure of Monos i al ogangl i os i de
,
GM
1
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Chap ter 1 1
.
LIGAND BINDING TO GM-1 GANGLIOSIOES — EFFECTS
ON LIPID MOBILITY
INTRODUCTION
Plasma membranes provide selectively permeable barriers between
cells and their environment. They control the amount and nature
of the substances that pass between or enter cells. They are
composed primarily o-f lipids and proteins. The lipids form a
fluid matrix in which the proteins are embedded (1). As such they
interact with each other, playing different but coordinated roles
in the
-functioning o-f the membrane.
In addition to lipid and protein, plasma membranes contain
carbohydrates. Membrane carbohydrates o-f euXaryotic cells are
covalently linked to either protein or lipid molecules
(glycoproteins and glycol i p i ds
, respectively). Glycoproteins and
glycol i p i ds associate and interact with one another and comprise a
membrane structure called the glycocalyx. The physiological
behavior and -function o-f the gl ycoconjugates contained within this
matrix are largely dependent upon their lateral mobility and
topographical distribution within the membrane bilayer and with
the type o-f phospholipid associated with them <2-5).
Both glycoproteins and glycol i p i ds are -found distributed
throughout the plasma membrane. They have been shown to serve as
cell surface receptors -for various hormones, for cellular
recognition markers, and -for viruses (6-10). Thus, glycoproteins
and glycol i p i ds via their surface carbohydrate moieties are
multi-faceted components of the plasma membrane that perform
26
specific roles in cellular communication, di f f eren t i at i on and
growth regulation.
In comparison to glycoproteins, relatively little is known about
the physical properties, organization, or receptor
-functions of
membrane glycolipids, particularly, the gl ycosph i ngol
i
p i ds
.
Recent studies indicate that glycolipids can modify various cell
surface
-functions (11-14). They may, like phospholipids, modulate
the activities o-f certain membrane proteins via direct interaction
(2, 15). Additionally, their function and organization may
contribute to the overall structural properties o-f the bila^er
matrix through interaction with membrane phospholipids (.16, 17).
Furthermore, gangliosides have been demonstrated to be receptors
for bacterial toxins (18-21), peptide hormones (15, 22-25),
viruses (26-28), neurotransmitters 129), and lectins (30, 31). It
is likely that the variation in oligosaccharide composition and
structure o-f these gl ycosph i ngol i p i ds and the variation in their
patterns o-f occurrence on various cell types permits the broad
receptor diversity o-f these molecules. However, in most cases, no
detailed models exist which can explain the median iam(s) by which
ganglioside receptors communicate biological stimuli to the cell
(32-35). Is it the interaction of tne ganglioside with other
molecules of the glycocalx, that is, other glycolipids or
glycoproteins through which gangliosides communicate with the
eel 1 ?
Recent studies have examined the influence of gangliosides on
27
the physical properties of cell membranes. Spec i 4 i cal 1 y
,
properties o-f gangl i osi de/phosphol i p i d mixtures in mu 1 t i - and
unilamellar dispersions o-f the monosi al ogangl i osi de
, GM , and
1
di palmi toyl phosphat i dyl chol i ne CDPPC) have been examined (36-41).
It was been shown that addition o-f gl ycosph i ngol i p i ds to
Phosphatidylcholine < PC) vesicles results in an increase in lipid
order (36, 37, 41.) , nd i ca t i ng a rol e for gangl , os , des
, n doma , n
formation and stabilization within the plasma membrane.
Additionally, it has been demonstrated that GM is miscible with
PC in lipid dispersions up to 25-30 mole V. GM (36, 41). However,
the nature o-f GM /PC at mixtures containing more than 30 mole V, is
yet to be completely resolved (36, 37, 41). Furthermore, when
GM /PC model membranes are fluid, that is, at temperatures above
the lipid phase transition o-f the PC species, GM gangl iosides are
1
randomly distributed throughout the bi layer. However, below the
transition temperature, some i nvest i gators be 1 i eve that clustering
o-f the GM gangl iosides occurs within the lipid matrix (39). In
contrast, in our laboratory (41) and in others (36, 37) evidence
has been obtained which suggests that gangl iosides are miscible in
PC in both the solid and -fluid phases.
Despite these model membrane studies on the molecular
organization of GM and its interactions with various phospholipid
species, the role played by GM as a membrane receptor and its
1
effects on membrane structure remains largely unexplained. GM
has been demonstrated to serve as a membrane receptor for cholera
28
toxin <18, 42-44), wheat germ agglutinin (31, 45), and the
galactose-specif ic lectin of B±£.±nus cnmmun±s beans <30, 46) in
both cellular membranes and in GM -containing liposomes. The
1
latter, has been -found to be a useful model system for the
investigation o-f agglutination o-f cells by lectins.
we report here our studies on the effects of lectin binding on
receptor motion and distribution using
GM /dielaidoylphosphatidylchol ine <DEPC) as a model membrane
system. Specifically, the interactions of cholera toxin and
peanut lectin <47, 48) with GM -containing DEPC unilamellar
1
liposomes will be examined to ascertain:
(1) The effects of ligand binding on the mobility
of GM receptor molecule.
1
<2) The effects of ligand binding on the mobility
of the phospholipid.
(3) The affects of the physical structure of the
phospholipid on binding of ligand to receptor.
To address these questions, the agglutination of GM /DEPC
1
vesicles will be monitored by following changes of both
o
fluorescence depolarization by 90 light scattering (49-51), and
fluorescence polarization ratios to measure the membrane dynamics
of these agglutination events. Our preliminary hypothesis is that
ligand binding reduces the mobility of gangliosides in fluid model
membranes and increases mobility in solid membranes.
Additionally, we propose that ligand binding increases the
mobility of phosphatidylcholine in fluid model membranes, but
- 2?
decreases mobility in solid membranes.
EXPERIMENTAL PROCEDURES
MATERIALS
Ganglioiside GM was obtained
-from Supelco (Bellefonte, PA). I,
2-dielaidoyl-3-sn-phosphatidylchol ine (DEPC), cholera toxin, and
peanut lectin were obtained
-from Sigma Chemical Company (St.
Louis, MO) and were used without
-further purification. Both the
cholera toxin and peanut lectin were reconstituted with
fluorescence buffer (1 OmtJ HEPES, 50md HC1
, P H 7.2) to a -final
concentration o-f 100 nmoles/ml. All solvents used were o-f
spectral grade (Fisher). Cls- and ±caas.-par i nar i c acids were
contributed by Dr. R. Simoni, Department or Biological Sciences,
Stanford University, Stanford, CA. The N-parinaroyl spingolipid
probe, N-iLaa£-par i naroyl gl ucocerebrosi de (tPnAGC) was
synthesized and characterized in our laboratory (41). The
2-C-Ls-pan naroyl phosphatidylcholine (cPnA PC) probe was the
generous gift of Dr. R. Welti, Department of Biochemistry, Kansas
University Medical Center, Kansas City, K3.
PREPARATION OF LIPOSOMES
Liposomes of di el a i doyl phosphat i dyl chol i ne (DEPC) and DEPC/GM
(80/20, mole/mole) were prepared by the ethanol injection
technique of Batzri and Korn (52) as modified by Welti and Silbert
(53). Solutions of phospholipid and glycol ipid in chloroform were
- 30 -
dried down under a continous stream o-f N . The lipid -film was
2 o
resuspended in 20 ml o-f absolute ethanol and warmed to 45-50 C.
This lipid solution was injected by means of a 25 ml Hamilton
o
syringe into 4.0 ml o-f degassed
-fluorescence buffer at 45-50 C.
This is an e thanol -water concentration o-f approximately 0.57. (v/v)
and about 400 nmoles total lipid per 4.0 ml. These unilamellar
liposomes were then analyzed by flourescence polarization
spectroscopy and light scattering methods as described below.
Previous analysis o-f liposomes prepared similarly in our
laboratory have been shown to contain 95-100X o-f the added
phosphatidylcholine and 98-100'/. of the added ganglioside (41).
FLUORESCENCE POLARIZATION SPECTROSCOPY
Liposomes, prepared as described above, were placed in a 2.0 ml
quartz cuvette in the thermostat ted , temperature controlled
cuvette o-f a Spex Fluorolog Spec tro-f uorome ter . Excitation
wavelengths were 320 nm for tPnA and its gl ycosph i ngol i p i
d
derivative, tPnA GC, and 325 nm for cPnA and its phospholipid
derivative, cPnA PC; emission was monitored at 420 nm for both
probes. Blank (fluorescence intensity without added probe)
emission at the lowest scan temperature was recorded for both
parallel and perpendicular emission (using vertically polarized
light for excitation), and the sample was then heated to the
highest scan temperature. Blanks were again recorded, and the
parinaric acid probe was added to the same cuvette. For
experiments using par i naroy 1 gl ycol i p i d or phospholipid probes, the
- 31
blanks were recorded using buffer alone. The liposomes were
prepared by resuspending the gangl i osi de/phosphat i dyl chol i ne
mixtures in an ethanolic solution of parinaroyl phospholipid
-for
injection into bu-f-fer as described above. Fluorescence emission
parallel and perpendicular to the excitation was monitored as the
o
sample was cooled at a rate o-f 0.75 C / minute, using a Neslab
Water Bath and Linear Temperautre Programmer. Data were analyzed
using the computer smoothing program previously described (54). No
corrections were made -for scattering depolarization (50), since
all samples had absorbances o-f less than 0.100 at the excitation
wavelengths. Data obtained by heating the mixtures rather than by
cooling were equivalent, implying that the structures formed are
equilibrium mixtures of the components. Additionally, liposomes
o
stored -for several days at 4 C gave identical
-fluorescence
polarization thermotropic pro-files when compared to -freshly made
liposomes, implying that the structures were stable with regard to
t ime (41)
.
OPTICAL STUDIES
The interaction o-f cholera toxin and peanut lectin with
GM -containing DEPC and DEPC liposomes was monitored by
1 o
fluorescence depolarization and 90 light scattering (49-51). The
o
?Ci light scattering was monitored at a wavelength of 450
nanometers. The effects of ligand binding to DEPC and DEPC/GM
(80/20, mole/mole.) on membrane dynamics was determined from
fluorescence polarization spectroscopy. Free fatty acid probes
32 -
were incorporated after liposome preparation by direct addition to
the liposome suspension after taking background measurements. The
final probe to lipid ratio was 1:200 in all cases. Fluorescence
polarization and light scattering were measured on a Spex
Fluorolog Spec trof 1 uorome ter . Titration studies of cholera toxin
U nmole / 10 ml or 100 nmoles / ml) and peanut lectin < 1 nmole /
10 ml, or 100 nmoles / ml) were performed by the direct addition
of ligand to the liposomes contained within the quartz cuvette.
The ligand solution was uniformly dispersed in the liposome
suspension by gentle continous stirring.
RESULTS AND DISCUSSION
The molecular motions of N-icaiLS pannaric acid ( tPnA)
, N-icans
parmaroyl gl ucocerebr os i de < tPnA GO, and N-c_Ls parinaroyl
phosphatidylcholine (cPnA PC) fluorescent lipid probes in
dielai doylphosphat idylchol ine (DEPC) model membranes containing
GM gang! i oi si des were studied during titration experiments with
cholera toxin and peanut lectin, in order to observe the effects
of ligand binding to gangliosides in mixed dispersions of
ganglioside and phospholipid. Estimates of rotational motion at
o o
5.0 +/- 0.5 C and 35.0 +/- 0.5 C were determined from fluorescence
polarization ratios, while the binding of lectin was monitored by
changes in light scattering.
Fluorescence polarization allows the monitoring of the rotation
exhibited by a fluorescent membrane probe under a uariety of
33
conditions (for example, temperature range or lipid content).
Thus, data obtained from
-fluorescence polarization studies can be
used to interpret not only the motion, but the order of the lipid
species under investigation as well. Depending on the type of
fluorescent probe employed, an investigator can use fluorescence
polarization technique to detect: (1) subtle changes in lateral
phase separations of minor lipid species of the membrane (61); (2)
phase transition in major lipid species of the membrane (62); and
(3) the specific lipid domains preferred by the probe whether in
mixed model membrane or in reconstituted 1 i p i d-prote i n systems
(63, 64).
Fluorescence polarization spectroscopy has been used to analyze
the physical properties of various lipid components in biological
and model membranes (33-60). These studies followed the molecular
motions of a relatively large fluorophore, 1, 6-di phenyl -1 , 3,
5-hexatriene (DPH). While these fluorescence studies have provided
relevent information on the structural integrity of membranes, DPH
as a membrane probe causes significant membrane perturbation which
affects the results obtained (65). This is not to imply that the
use of fluorescence polarization spectroscopy is not a useful and
advantageous technique for analyzing lipid interactions. Rather,
it is to suggest that ideal membrane probes to carry out such
studies should minimize membrane perturbation in order to minimize
difficulties in interpretation of the data.
For these studies we have employed derivatives of the
- 34 -
naturally-occurring ds- and Icacs-par i nar i c acid molecular probes
first prepared and characterized by Sk 1 ar (65). Unlike many other
fluorescent membrane probes these molecules do not perturb the
membrane structure and are biological in origin. Because they
resemble integral membrane components they can be readily
incorporated into either eukaryotic or procaryotic phospholipids
(.66, 67) as well as into artificial and biological membrane
systems (63, 68). Cxs-par i nar i c acid has been -found to resemble an
unsaturated fatty acid and is incorporated into the fluid lipid
layer. In contrast, leans-par i nar i c acid resembles a saturated
fatty acid and is preferentially located within the solid lipid
phases of the membrane. Thus, by employing these two isomeric
fatty acid probes, it is possible to detect both lipid phase
transitions (with cPnA) and lipid phase separations (with tPnA)
(61 ) .
For these experiments, tPnA and tPnA GC were employed to detect
lipid phase separations during the binding of lectins to DEPC/GM
(80/20, mole/mole) liposomes. In binary mixtures of
phospholipids, tPnA exhibits a preference for solid phase lipids
(54, 61), The tPnA GC sphingolipid probe exhibits a preference for
solid phase glycol i p i ds
.
In DEPC/GM vesicles, by virtue of its
1
resemblence to natural gl ucocerebros i de (GC) it should behave as
an analogue of the glycol ipid component. Therefore, tPnA GC is
likely to be associated with the ganglioside fraction of our
liposome system. However, the cPnA PC probe shouid detect the
35
DEPC transition in the phosphatidylcholine <PC) domain, based on
its resemblence to naturally-occurring PC C54, 62). Furthermore,
cPnA PC has been demonstrated to exhibit a preference for the
fluid lipid phase in mixed PC membranes regardless of head group
(63). Therefore, the cPnA PC probe should be enriched in the DEPC
enriched domains in our system (Table 1).
LIPID INTERACTIONS BETWEEN GM AND DEPC IN MODEL SYSTEMS
1
Pure GM in aqueous suspension form spheroidal micelles (69-71)
I
and does not display a thermotropic phase transition over the
o
temperature range from 12-83 C (36). Pure monogl ucocerebros i de
,
likewise, has no detectable phase transition ouer a similar
o
temperature range (10-75 C) (72). In contrast, the major model
membrane component, DEPC, in aqueous solutions forms extended
lamellar bi layers (73). In our laboratory, DEPC has been
o
demonstrated to exhibit a melting temperature between 10-13 C
(41). DEPC membranes containing up to 30 mole V. GM retain the
1
bi layer or lamellar structure (70). The type of lamellar
structures formed, is determined primarily by the balanced
interactions between their head groups, which are normally
repulsive, and between their hydrophobic tail groups (74, 75).
Incorporation of more than 30 mole '/. ganglioside in PC results in
a marked physical change in structure leading to the formation of
mixed micelles (69-71). Results from our laboratory correlate with
these observations (41). Upon addition of increasing amounts of
GM to PC liposomes (up to 25-30 mole '/.) an increase in the
1
36
transition temperature o-f the PC species was observed. In SM /PC
mixtures, the phase transition o-f the PC, detected by
-fluorescence
o
polarization o-f cPnA will shift from 10-13 C for pure DEPC up to
o
20-22 C for PC/GM mixtures of 75/25 mole/mole. Thus,
1
incorporation o-f GM into PC bilayers results in a higher
1
fluorescence polarization ratio which indicates a more ordered PC
lipid phase. The phase transition temperatures obtained in this
particular study also demonstrate an increase in lipid order as
exhibited by the change o-f the melting temperature o-f DEPC. The
o
melting temperature of DEPC shifts from about 17 C in DEPC
o
liposomes to 23 C -for DEPC/GM liposomes (80/20, mole/mole)
1
(Figure 4). These data give us con-fidence that our fluorescence
polarization studies can be interpreted based on previous
fluorescence (41) and calorimetric (36, 37) data.
LIGAND INTERACTION WITH LIPOSOMES CONTAINING GANGLIOSIDES —
DEMONSTRATION OF AGGLUTINABI LITY
DEPC/GM (80/20 mole/mole ) liposomes were used as a model
1
system for the investigation o-f agglutination o-f liposomes by
o
lectins. Binding studies were done it 5.0 +./- 0.5 C and 35.0 +,--'-
o
0.5 C by adding increasing concentrations of either of two
lectins, namely, cholera toxin and peanut lectin to different
preparations of liposomes containing one o-f our three
-fluorescent
probe species (for discussion of probes refer to above).
When lectin was added to the DEPC/GM liposomes increases in the
1
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o90 light scattering were observed (Figure 5). The increase in 90
light scattering represents agglutination of liposomes. In both
cholera toxin and peanut lectin the binding event was rapid. This
was to be expected -for the cholera toxin which exhibits a K value
" 9 d
o-f 1.1 x 10 U in purified liver membrane preparations and 4.6 x
10 M for fat cells (43). The K o-f peanut lectin as not been
d
reported. However, incubations at the var i ous conce trat i ons o-f
peanut lectin tor up to 90 minutes did not alter the amount o-f
detected binding. The same was observed
-for cholera toxin. Thus,
the observed increases in light scattering represent a rapid
agglutination event o-f DEPC/GM vesicles and the -formation of
1
liposome clusters by these lectins. However, the addition o-f
cholera toxin to DEPC/GM vesicles agglutinated the DEPC/GM
1
iliposomes appreciably more (5-6 times higher scattering
depolarization values) than did the peanut lectin (Tables 4 and
5). Furthermore, these agglutination events were demonstrated to
be spec i -f ical 1 y related to ligand interaction with the GM
receptor molecules because neither lectin was able to agglutinate
liposomes composed solely of DEPC. Additionally, the extent to
which DEPC/GM liposomes were agglutinated was increased as the
molar ratio of lectin to GM was increased (receptor in exress-
1
Table 2, and Figure 5). During these binding events, agglutination
o-f DEPC/GM liposomes was not temperature dependent. However,
agglutination of the DEPC/GM liposomes was slightly better at
1
lower temperatures (Tables 4 and 5>
.
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In support of our data, similar interactions have been reported
between the lectin -from Ricinuj comamnls (30) and wheat germ
agglutinin (WGA) (31, 76) with PC liposomes containing GM
1
gangl i osi des. Riciaus cnmrniinia lectin reacts spec i f i cal I y with
the terminal galactose of GM (46, 77, 78). While UGA has been
1
demonstated to interact with the sialic acid residue on GM (45,
1
79). In neither study was the lectin able to bind to vesicles
containing only PC. However, both lectins cause significant
agglutination of PC liposomes containing GM . This observed
1
formation of liposome clusters by 1 ec t i n-gangl i os i de interaction
in gangl i osi de/PC model membranes has been suggested to resemble
cell agglutination (30). Thus, our approach of employing PC
vesicles containing gangl iosides should prove useful as a model
for furthering the investigation of cellular agglutination
mechan i sms
.
The lesser extent to which peanut lectin was able to bind to GM
1
in the mode! membranes may be a result of steric hinderance from
the sialic acid residues present on GM molecules. Peanut lectin
1
has been demonstrated to bind to mouse, rat, guinea pig, and human
lymphocytes, but only after neuraminidase treatment.
(Neuraminidase hydrolyzes sialic acid residues from glycoproteins
and gl ycol
i
p i ds . ) Treatment of neurami n
i
dase-treated lymphocytes
with *-gal ac tosi dase significantly decreases the agglutination of
the cells upon addition of peanut lectin (48). These data imply
that peanut lectin reacts specifically with terminal galactose
39 -
residue and its ability to interact with a receptor is reduced by
the presence of sialic acid on the glycol ipid or glycoprotein.
However, we cannot directly test this hypothesis, since the single
sialic acid in GM
,
is very resitant to neuraminidase hydrolvsis
1
(43,84). From our data, however, peanut lectin was still observed
to agglutinate DEPC/GM liposomes. Increases in agglutination
1
during titration, on the average of 1.3 fold higher, were
obtained, but only at the lower binding temperature. Lectin
dependent increases in light scattering were not detectable at
o
35.0 C. Furthermore, it can be argued for the binding of both
cholera toxin and peanut lectin to GM that the surface changes
1
resulting from lectin binding one receptor molecule on one
liposome may be sufficient to permit interaction of the lectin
with available receptors on adjacent liposome vesicles. This
resulted in the agglutination of DEPC/GM liposomes we observed
1
for situations of receptor excess.
LIGAND INTERACTION WITH LIPOSOMES CONTAINING GANGLIOSIDES --
INFLUENCES ON MEMBRANE FLUIDITY
Agglutination of gangl i os i de-con t a i n i ng liposomes is dependent
upon changes in both the topological distribution of the
gangl ioside receptor and membrane fluidity. Studies examining the
topographies of glycol
i
p i ds as membrane receptors are being
pursued C3-5, 31, 32). However, the molecular aspects of membrane
fluidity in agglutination processes involved in cellular adhesion
during de>. '.pment, differentiation, oncogenesis, and
40
I igand-receptor interactions is still speculative. To address the
issue o-f membrane -fluidity in cell agglutination, we chose to
examine the a-f-fects on membrane
-fluidity o-f 1 ec t i n-gangl i osi de
complexes and cluster
-formation in DEPC/GM model membranes.
1
From our -fluorescence polarization data <data summarized in
Table 3), cholera toxin was shown to disorder DEPC/GM bi layers at
1 o
temperatures below the phase transition (5.0 +/- 0.5 C) o-f
DEPC/GM (80/20 mole/mole). This disordering o-f membrane 1 i d i ds
was interpreted
-from the observed decreases in
-fluorescent
polarization ratios exhibited by each o-f three membrane probes
employed. Spec i
-f i cal 1 y , the disordering changes in membrane
structure o-f the DEPC component was detected with both the
l£AD5-par i nar i c acid ( tPnA)
,
the
_t.ca£i.s-par i naroy 1 gl ucocerebrosi de
•; tPnA GO, and the iis-psrinaroyl phosphatidylcholine (cPnA PC)
probes. The tPnA probe should be monitoring the molecular motion
o-f all major membrane components. Based on previous data, the
cPnA PC probe should monitor the molecular motion o-f the DEPC. The
tuaa^-par i naroyl gl ucosy 1 cerebros i de (tPnA GO sphingolipid probe
probably associates mainly with the minor GM -fraction. No et-fect
1
on membrane -fluidity was detected tor titration studies performed:
(1) with cholera toxin or peanut lectin to vesicles composed of
DEPC at either temperature; (2) with cholera toxin to DEPC/GM at
o 1
temperatures (35.0 +/- 0.5 O above the melting temperature (T )
m
o-f DEPC/GM (80/20, mole/mole); or (3) with peanut lectin to
DEPC/GM at either low or high binding temperatures.
1
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We considered the possibility that the rapid increase in light
scattering (i.e., the rapid binding of lectin to GM as presented
1
above) may be depolarizing the fluorescence emission. Previous
investigators have reported that scattering can s
i
gn i f i can t 1
y
depolarize
-fluorescence emission in both biological and model
membranes <51). In particular, Lentz, jd Mi.., (50) have reported
that appreciable increases i n 1 i gh t scattering by membranes affects
polarization ratios. By employing the method described by Teale
(4?) we were able to determine that the fluorescence polarization
ratios presented in Table 3 were not affected by light
scattering. The cnange in optical density of our liposome
suspensions before and after addition of up to 5.0 nanomoles of
either cholera toxin or peanut lectin was
-jery small and we could
not detect changes in the polarization ratio upon dilution of the
samp 1 e
.
Reidler (83) examined the mobility of selected fluorescent lipid
analogs on cell membranes. Through the interactions of various
effector molecules with cell membranes, he was able to demonstrate
the "-free" mobility of GM within the membrane; that is, GM
1
1
mobility is not the result of cy toske 1 e tal interactions. In
experiments performed with cholera toxin to examine glycol ipid
mobility via a fluorescent glycol ipid probe, Reidler was able to
demonstrate toxin dependent clustering of GM analogs in cell
1
membranes. He concluded that the head groups of bound GM
molecules, behaved as a "non-free draining unit." Furthermore,
- 42
the formation of the fluorescent patches caused a reduction in the
mobility of the gl ycol i p i d-assoc
i
ated membrane probe. However,
Reidler was unable to address the interactions of glycolipid with
phospholipids in his studies of cholera toxin-GM binding.
1
Furthermore, he was unable to demonstrate the consequences of
1 igand interaction with ganglioside receptors and on membrane
structure. However, with careful selection of fluorescent probes
known to partition between solid/fluid lipid phases and to
associate within specific lipid fractions, we were able to
demonstrate that binding of cholera toxin to GM within DEPC/GM
1 1
membranes, the ganglioside receptors are agglutinated causing the
subsequent disordering of the membrane lipid.
The biological implications of this observation include the
possiblity that the interaction of ganglioside receptors can
modify the cell membrane. Such events can significantly alter the
dynamics of membrane structure. Disordering of membrane lipids by
glycolipid clustering events thus can lead to changes in membrane
permeability or cell surface function.
In summary, we have demonstrated:
<1> Cholera toxin and peanut lectin agglutinate
DEPC/GM-1 model membranes. Furthermore,
these agglutination events were specifically
related to 1 i gand interaction with the GM-1
receptor molecules.
<2> The extent to which DEPC/GM-1 liposomes
were agglutinated was increased as the molar
ratio of lectin to GM-1 was increased.
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(3) Agglutination of DEPC/GM-1 liposomes did
not exhibit a significant temperature
dependence, although agglutination was slight
better at the lower binding temperature.
<4> Cholera toxin agglutinated DEPC/GM-1
vesicles better than peanut lectin. Binding
by peanut lectin may have been appreciably
less than that exhibited by cholera toxin
because o-f steric hinderance by the sialic
acid present on GM-1
.
(5) Cholera toxin binding to GM-1 within
DEPC/GM-1 model membranes causes
agglutination o-f the ganglioside receptors
and the subsequent disordering of the
membrane 1 ipid. Such an event can
significantly alter membrane dynamics
which in turn can lead to changes in
membrane permeabilty or cell surface
f unc t i on
.
ly
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Eo.©u£.£ 3: Fluorescent membrane probes.
(Diagram adapted -for L. Sklar, PhD Dissertation,
Stan-ford University, 1976)
From le-ft to right, upper monolayer:
AS = anthroyl strearic acid
DPE = dansyl phosphat i dy 1
e
thanol am i i ne
OC = octadecyl carbocyanine
.Leans. PnA = a I 1 -.tcans-par i nar i e acid
-trAQS PnA GC = all-lrAns-parinaroyl
gl ucocerebros i de
From le-ft to right, lower monolayer:
ONS = octadecyl naph thy 1 am i ne sulfonate
DPH = d
i
phenyl hexatr i ene
ANS = anilino naph thy 1 am i ne sulfonate
NS = nitroxide strearic acid
P = perylene
cia PnA PC = cis-par
i
narovl
phosphat i dyl chol ine
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labia 1: Fluorescent parinaric acid membrane probes with
their membrane counterparts, and their lipid phase and location
p r e -f e r e n c e s
.
Parinaric Membrane Lipid Phase Liposome Fraction
Acid Probe Counterpart Pre-ference Assoc i ated Wi th
< Locat i on
,
exper imen tal )
t PnA Saturated solid Major
Fatty Acid Membrane
Componen t
t PnA GC Neutral solid GM-1 Ganglioside
Gl uco-
Cerebrosi de
c PnA PC Phosphatidyl-
-fluid Dielaidoyl-
Chol i ne Phosphat idyl -
Choi ine (DEPC)
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Ej-gut* 4: Temperature Dependence o-f tPnA Fluorescence
Polarization in Liposomes Containing DEPC and GM .
1
Liposomes were prepared and analyzed as described in the
experimental procedures. tPnA (-final probe/1 ipid ratio = 1/200,
mole/mole) was added, the 1 iposomes were cooled at a rate of
o
0.75 C/min in a Spex Fluorolog spec tro-f 1 uorome ter . Data were
collected, blanks were subtracted and smoothed curves were
generated as previously described (41). The open circles represent
DEPC liposomes and the closed circles represent DEPC/GM (80/20,
1
mole/mole) liposomes. Panel A is a plot o-f Fluorescence
Polarization Ratios versus temperature and Panel B which contains
the same data as Panel A, is a plot o-f a derivative o-f the
•fluorescence polarization ratio versus temperature. Similar
results were obtained with t PnA, t PnA GC, and c PnA PC
fluorescent probes.
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Eiguce. 5: Ligand Interaction With DEPC Liposomes Containing GM-1
o
Gangliosides — Demonstration of Aggl u t
i
nabi 1 i ty via 90 Light
Scatter i ng.
DEPC/GM-1 (80/20, mole/mole) liposomes were prepared as
described in the experimental procedures. Binding studies wers
o o
done at 5.0 /- 0.5 C and 35.0 +/- 0.5 C by adding increasing
concetrations o-f either o-f the two lectins, cholera toxin and
peanut lectin to different preparations of liposomes containing c
o
PnA PC. 90 light scattering was monitored at 450 nm . The open
circles represent DEPC liposomes and the closed circles represent
o
DEPC/ GM <80/20 mole/mole) liposomes. The left panel is the 90
light scattering of liposomes in the presence o-f cholera toxin and
o
the right panel is the 90 light scattering o-f liposomes in the
o
presence of peanut lectin. Similar plot; - ?0 light scattering
versus nanomoles of lectin added were obtained at both 5.0 and
o
35.0 C and for all three probes.
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lAhl* 2: Ratios o* Cholera Toxin and Peanut Lectin Ligands
to the GM-1 Receptor.
Ligand concentrations were 1 nanomole per 10 micol iters
(or 100 nanomoles per milliliter).
Ratio o-f Ratio o-f Nanomoles of Mi crol i 1 i ters o-f
Ligand to GM-1 to Ligand Ligand Added
GM-1 Ligand
0.00 0.0 0.0
0.02 50 0.4 4.0
0-03 20 1.0 10.0
0.10 10 2.0 20.0
0.20 5 4.0 40.0
0.25 4 5.0 50.0
Titration binding studies were performed with receptor excess.
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Iahlt 3: Fluoresence Polarization Ratios o-f Cholera Toxin
and Peanut Lectin Binding to Di e 1 a i doyl phosphat i dyl chol i ne
Liposomes With and Without QM-1 Gang! i osi des
.
Ligand Liposome Fluorescent Fluorescence Polarization Rati
Compo- Probe Binding at: o
s i t i on Employed 5 C 35 C
Receptor to Ligand Ratio
100:0 5:1 100:0 5:1
peanut
lectin
DEPC t PnA 2.02 2.03 1 .33 1 .39
t PnA GC 1 .96 1 .95 1 .33 1 .38
c PnA PC 1 .76 1 .SO 1 .21 1 .19
peanut
lectin
DEPC
+
t PnA 2. 15 2.10 1 .27 1 .42
GM-1 t PnA GC 2.05 2.01 1 .39 1 .34
c PnA PC 1 .79 1 .88 1 .19 1 .20
chol era
tox i n
DEPC t PnA 1 .98 2.01 1 .23 1 .31
t PnA GC 1 .94 1 .95 1 .30 1 .35
c PnA PC 1 .49 1 .48 1 23 1 13
chol era
tox i n
DEPC
+
t PnA 2.00 1 .94 1 37 1 36
GM-1 t PnA GC 1 .95 1 .85 1 31 1 23
c PnA PC 1.77 1 .55 1 24 1 17
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lAble i: Data Summary of Peanut Lectin Interaction With
GM-1 Gangl iosides.
Li posome
Compos i t i on
Fluorescent
Probe
F] uorescence
Pol ar i zat i on
o
90
Light
oRat
5 C
o o
35 C
Scat ter i og
5 C 35 C
DEPC (100) t PnA NC NC NC NC
t PnA GC NC NC NC NC
c PnA PC NC NC NC NC
DEPC + GM-1
< 80/20 >
t PnA NC NC 1 .75X NC
t PnA GC NC NC 1 .20X NC
c PnA PC NC NC NC NC
Mean = 1 . 32X
NC - No significant change between fluorescence polarization
ratios between no ligand and 5:1 receptor to ligand
ratio.
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labia 5: Data Summary of Cholera Toxin Interaction With
GM-1 Gangl i os i des.
Li posome
Compos i t i on
Fl uorescen
t
Probe
Fl uorescence
Pol ar i rat i on
o Ratio o
5 C 35 C
L
8c a
5 C
?0
ight
t ten i og
35 C
DEPC (100) t PnA NC NC NC NC
t PnA GC NC NC NC NC
c PnA PC NC NC
Mean =
1 .30X NC
1 . 10X
DEPC GM-1 t PnA 2.00->l,?4 NC 6 . 1 4X 4 . 40X
(80/20)
t PnA GC 1.95-M.35 NC 6.00X 6 . 1 6X
c PnA PC 1.77-M.55 NC 7.1 OX 4 . 50X
Mean = 6.41X 5 . 1 6X
NC — No significant change between
-fluorescence polarization
ratios between no Itgand and 5:1 receptor to 1
i
gand ratio.
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Chapter III.
INTERACTION OF GROWTH-INHIBITORY
BRAIN CELL SURFACE GLYCOPEPTI DES WITH CELLS
INTRODUCTION
The growth inhibitory activity ot" Brain Cell Surface
Glycopept ides <BCSG) has been studied (1-7). It was determined
that GM monosi al ogangl i osi de enhanced the sensitivity of cells to
1
membrane ganliosides constituted the biological receptors
-for BCSG
the effects of the inhibitor (7). The possibility that GM
to
was considered. However, even though exogenously incorporated GM
enhances cellular sensitivity to growth inhibition by BCSG (6),
incorporation of GM onto cell membranes does not increase the
1 125
ability of radioiodinated BCSG ( I-BCSG) to bind to the cell
125
surfaces (34). We could not detect I-BCSG binding to GM using
1
several ia uxtco 1
i
gand-recep tor binding assays (see chapter 4>
.
Therefore, we concluded GM does not serve as a membrane receptor
1
for BCSG. However, GM does serve to modulate the biological
1
act i v i ty of BCSG (31 > .
These studies describe procedures used to delineate now the
growth inhibitor interact?* with the plasma membrane.
125
Calculations based on the binding of I-BCSG to 3T3 mouse
4
fibroblast cells imply that there are about 1-2 X 10 receptor
molecules per cell (31). we have utilized F745 Friend
erythrol eukemi c and AG3 mouse myeloma cells to study the
interaction of BCSG with intact cells. These two cell lines were
125
selected because: (1) they bind I-BCSG; (2) they proliferate
rapidly; and (3) they grow in suspension culture. These
characteristics of F745 and AG8 cells make them useful in
62
experiments designed to determine the identity and characteristics
of the plasma membrane components which might be involved in
BCSG-membrane interaction.
EXPERIMENTAL PROCEDURES
MATERIALS
GROWTH INHIBITORY GLYCOPEPTI DES CBCS6)
125
Radi 01 odi nated brain cell surface gl ycopep t i des ( I-BCSG) were
the generous gift of Dr. T. C. Johnson, Division of Biology,
Kansas State University, Manhattan, KS (1-7).
CELLS
The F745 Friend ery throl eukemi c cells, provided by Dr. D. Luse
(Department of Biochemistry, University of Cincinnati Medical
School, Cincinnati, OH) were cultured in modified Eagle's medium
(MEM) (Flow Laboratories, McLean, VA) with 5X newborn calf serum
(NBCS) (Sterile Systems, Inc., Logan, UT) in 20mM HEPES,
glutamine, and nonessential amino acids at 37 C and 5X CO . The
•?
AG8 mouse myeloma cells were kindly contributed by Dr. G. W.
Fortner (Division of Biology, Kansas State University, Manhattan,
KS)
.
The AG8s were cultured in Dulbecco's modified Eagle's medium
(DMEM) (Flow Laboratories, McLean, VA) containing 1 OX fetal calf
serum (FCS) (Sterile Systems, Inc., Logan, UT) , 20mM HEPES,
glutamine, and nonessential amino acids at pH 6.8-7.3 in an
atmosphere containing 1 OX CO .
2
63
ENZYMES
Neuraminidase (8, ?) , trypsin (10, 11), alpha-chymotrypsin
(11-14), and proteinase K (15) were obtained -from Sigma Chemical
Company (St. Louis, MO). Cells were enzymat i cal 1 y digested
-for 40
minutes with either 1.0 unit/ml neuraminidase, l.Omg/ml trypsin,
1.0 mg/ml al pha-chymotryps
i n , 0.5 mg/ml trypsin and 0.5 mg/ml
alpha-chymotrypsin, or 0.25 mg/ml proteinase K prior to performing
the cell binding assay (20).
Neuraminidase, prepared from Closlnxdium p.e.r.£r_iaQe.s . is a
sialidase receptor destroying enzyme, one unit of which has been
determined to liberate 1.0 umole o-f £J-ace tyl -neuram i c acid (NANA)
o
per minute at pH 5.0 at 37 C (9). Trypsin,
-from beef pancreas,
specifically hydrolyzes peptides, amides and esters at lysine and
arginine carboxyl bonds (11-14). Alpha-chymotrypsin, also purified
from beef pancreas, is a member of a group of proteolytic enzymes
derived from chymo tryps i nogens A and B. The chymotryps i ns have
relatively broad specif ici ty, hydrolyzing aromatic amino acids,
amides, and amino acyl moieties (11-14). Proteinase K causes
nonspeicific hydrolysis of proteins (15).
METHODS
CELL BINDING ASSAY
6
The cells were counted and 2.0 X lu cells were used per
replicate. The appropriate volume of cells was pelleted by
- 64 -
centrifuging at 1000 rpm for fiv, minutes. The cell pellets were
resuspended and washed twice in 2.0 ml Hanks BBS, pH 7 > (i*j
125
For binding of I -BCSG to cells 300 ul total volumes are used
(four repl icates were contained within one reaction tube). The
binding assays were carried out in Falcon polystyrene 12 X 75 mm
test tubes pretreated 24-48 hours at 4 C with 57. Bovine Serum
Albumin <BSA>. At the end o-f the incubation period, 200 ul
aliquots were removed. The reaction halted by adding the 200 ul
sample into 2.0 ml cold Hanks BBS (pH 7.2) and centrifuged at 1000
rpm -for
-five minutes. The cell pellets were washed a second time
125
with 0.5 ml Hank's BBS CpH 7.2) and the amount o-f I -BCSG bound
was determined by counting gamma emission in a Packard Multi-Prias
Gamma Coun t er
.
RESULTS AND DISCUSSION
A number o-f studies have demonstrated that exposure of cells to
glycol i p i ds modifies various cells surface functions (21 -24:.'.
ul vcosph i ngol i p i ds added exogenous'-/ to cells in culture ape
incorporated into the plasma membranes where they have been shown
to be capable of inhibiting cell growth and modify growth behavior
(22, 25-27). Specifically, GM and GM gangliosides have been
1 3
demonstrated, in serum-free medium, to inhibit cell growth when
incorporated into cell membranes (23, 29). Furthermore, GM and
1
GM were shown to be capable of inhibiting growth
3
factor-stimulated mitogenesis, possibily through modulation of
growth factor receptor function. One mechanism proposed for this
65
modulation of membrane receptors is via inhibition of tyrosine
phosphorylation stimulated by growth factor binding (29). We have
observed enhancement ot" growth inhibition by the growth- i nh i bi tory
BCSG upon incorporation o-f exogenous gangliosides and have
speculated that gangliosides modulate BCSG-recep tor -function (31).
However, before analyses o-f gl ycol i p i d-recep tor interactions can
be pursued, the membrane components involved in BCSG-membrane
interaction must be identified and characterized.
125
ANALYSIS OF I -BCSG INTERACTION WITH CELLS
DEMONSTRATION OF MEMBRANE GANGLIOSIDES
The F745 Friend ery throl eukem i c cells and AGB mouse myeloma
cells selected for this study have been demonstrated by the
ganglioside isolation procedure of Irwin and Irwin a?) and by-
thin layer chromatography (TLC) to contain membrane gangliosides
(data not shown;. F745 and AGS membrane gangliosides
chroma tographed on TLC plates were developed with re sore i no!, a
reagent which specifically interacts with the sialic acid present
within the ganglioside head groups US). F/45 ceils contained
predominantly GM and GD ganglioside species
, as well did the
1 la
AG3s
.
125
I -BCSG BINDING TO CELLS
125
I-BCSG has been demonstrated to bind to cells in culture
125
(31). We demonstrate here that I-BCSG is also capable of
- 66 -
binding to both F745 and AG8 cells. This binding has been
demonstrated to be both number and time dependent. (Table 6 and
125
Figure 6) Calculations based on the binding of I -BCSG with
125
intact cells, indicated that about 750 molecules o-f I-BCSG were
able to bind per F745 cell whereas, AG8 cells bound about 1825
125
molecules of I-BCSG per cell. This was about 2.4 times more
than the F745s. Thus -for -further investigations of BCSG membrane
interaction, we employed the AG8 mouse myeloma cells. It should
be noted that both these cell lines bind considerably less than
has been shown for our target cell line, 3T3 mouse fibroblasts.
4
3T3 cells have been determined to bind 1-2 X 10 molecules of BCSS
per cell and are sensitive to BCSG effects. The reduction
125
observed for I-BCSG binding to F745s and AG8s may partially
contribute to the refractive nature these cells exhibit toward
BCSG.
EFFECTS OF ENZYMATIC DIGESTION OF CELLS ON THE ABILITY OF
125
I-BCSG TO BIND
The enzymatic digestions o-f AG8s were performed at relatively
high concentrations of neuraminidase, trypsin, al pha-chymotrypsi n
,
and proteinase K. Enzymatic digestion had dramatic effects on the
125 125
ability of I-BCSG to bind (Table 7). The effects on I-BCSG
binding to cells after treatment with trypsin was significantly
decreased. Furthermore, relatively moderate decreases in binding
were observed after reaction with chymotrypsin and proteinase K.
Double digestion of cells with trypsin and chymotrypsin resulted
6?
in a slight decrease in binding relative to trypsin treatment
alone. Our interpretation of these data is that a membrane
protein may constitute the biological receptor for BCSG.
125
It is interesting to note the effects on I-BCSG binding to
cells after treatment with neuraminidase. Neuraminidase digested
cells showed a slight enhancement o-f the amount o-f the growth
inhibitor able to bind to the cells. (Table 7) This result was
not surprising since in previous studies neuraminidase liberation
of N-acetyl-neuraminic acid (NANA) from eukaryotic cell surfaces
has been shown to influence not only the social behavior between
cells, but receptor-recognition events as well (30). Other studies
(19, 20) have reported that neuraminidase converts the more
complex membrane gangliosides to GM and that the GM structure is
1 1
resistant to neuraminidase activity. In specific consideration of
the former, GM has been shown to enhance the growth-inhibitory
effects of BCSG on some cell lines (6). However, neuraminidase
hydrolyzes sialic acid from both glycol i pi ds and glycoproteins.
Therefore, an alternative explanation for the increase in
I-BCSG binding to neuram i n
i
dase-treated cells was that this
digestion increased or exposed new BCSG binding sites on
gl ycoprote i ns.
In summary, we have demonstrated
(1) F745 and AG8 cells contain membrane qangliosides
GM-1 and GD-la.
(2) 125I-BCSG was able to bind to both F745 Friend
erythrol eukemi c and AG8 mouse myeloma cells.
- 68
Calculations based on these binding data indicated
that F745s contain about 750 BCSG receptors per
cell and that AG8s contain approximately 1825
BCSG receptors per cell. Determination o-f actual
receptor numbers is awaiting non-specific binding
assays wi th BCSG.
(3) Enzymatic digestion o-f AG8 cells with
prote i n-spec i
-f i c enzymes si gn i -f i can 1 1 y decreased
125I-BCSG bindin implicating a membrane protein
involvement in BCSG-membrane interaction.
(4) Neuraminidase treatment o-f AG8 cells slightly
enhanced 125I-BCSG binding suggesting that
membrane gangliosides
-function in the modulation
o-f the BCSG receptor via their mobility and head
group interactions.
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Iahla 6: 125 I - Growth Inhibitory Brain Cell Surface
Glycopep tides Direct Binding to Cells — Demonstration o-f
Cell Number Dependence.
F745 2X10
Ce1
'
Line Cell Number cpm 125 I - BCSG Bound
Above Background
387
2X10 1721
5
AGS 2X10 3
2 X 10 301?
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Eicjucfi. *l Binding of 125 I - Growth-Inn i bi tory Brain Cell
Surface Gl ycopep t i des to F745 Friend Ery throl eukemi c and AG8
Myeloma Cells — Demonstration oi 125 I - BCSG Binding as a
Func t i on of Ti me .
Cell binding experiments were performed while holding the cells
on ice. 200 microliter aliquots of the reacting suspension were
removed at 0, 15, 30, 60, and 240 minutes post-125 I - BCSG
addtion. The cells in each sample were pelleted and washed twice
in ice-cold Hanks BBS. The amount of 125 I - BCSG bound was
determined by counting gamma emission in a gamma counter. The
triangles represent the results of 125 I - BCSG binding to the AG8
cells and the squares to the F745 cells.
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labia 2: E-f-fects o-f Enzymatic Digestion o-f AGS Myeloma
Cells on the Binding o-f 125 I - Growth-Inhibitory Brain Cell
Sur-face Gl ycopep t i des .
Enzyme Total Enzyme cpm 125 I - BCSG Bound
Concentration Above Background
Trypsi n
< . 5mg/ml
)
+
Chymotrypsi n
(0 .5mg/ml
None 0.0 mg/ml 8277
Neuraminidase 0.1 unit/ml 11,147
Trypsin 1.0 mg/ml 2803
Chymotrypsin 1.0 mg/ml 5031
1 .0 mg/ml 2160
Proteinase K 0.25 mg/ml 3813
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Chapter IV.
FUNCTIONAL ROLE OF GM-1 GANGLI OS! DES
IN THE MECHANISM OF INTERACTION OF
GROWTH-INHIBITORY BRAIN CELL SURFACE GLYCOPEPTI DES WITH CELLS
INTRODUCTION
Growth of normal mammalian cells in culture is regulated in
manys way, one o-f which is a process known as contact inhibition
(1). For example, normal cells growing in a monolayer will stop
growing when they come into contact with neighboring cells. This
social communication between cells is exhibited by all normal
cells, and is a process which is presumably lacking in cancerous
or transformed cells (2). The molecular basis of this phenomenon
o-f contact inhibition is unknown, but it is believed to occur at
the level o-f the plasma membrane <3-5>.
Cells at remote locations relative to one another are also
capable o-f communicating. This interaction occurs via binding o-f
extracellular substances, soluble ligands, and hormones. Hormones
act as chemical messengers between cells and are capable o-f
a-f-fecting a wide range o-f cellular responses involved in either
long-term or short-term regulation o-f growth and metabolic
ac t i v i ty t 6-3) .
Speci-fic receptors on the cell surface are targets for the
action of most soluble ligands and hormones <.6, 3-10). The
1 i gand-recep tor complex can exert its effect on the cell by either
of three known mechanisms. The first, is the internalization of
the 1 i gand-recep tor complex. The second mechanism involves the
activation of a membrane-bound enzyme. By the third mechanism,
information is conveyed into the cell via a second messenger
- 77
system (10). Cellular communication can also be achieved through
ion fluxes and pumps (11, 12). Small molecules can be transported
via membrane proteins. Examples of this type of communication can
be observed in neuronal or muscular membranes or at gap junctions
( 13) .
One class of structural membrane components which are present in
high conce trat i ons in plasma membranes (14-18) and are known to
participate in various cell surface recognition functions are
gl ycosph i ngol i p i ds (8, 9, 19-29). These molecules possess a
hydrophilic sialic acid-containing oligosaccharide head group and
are characterized by broad structural diversity (8, 9, 30). These
characteristics allow gangliosides to serve as receptors for
bacterial toxins '-'27, 31-35), plant lectins ( 36-38)
, viruses (22,
24, 39), and hormones (19, 40-43). Receptor function has been
demonstrated for gangliosides naturally present in plasma
membranes whether functionally incorporated into plasma membrane
(40, 44), contained in liposomes (27, 40, 43), adsorbed onto
plastic surfaces (45, 46), or immobilized on thin layer
chromatography (TLC) plates (47). Furthermore, when added
exogenously to cell cultures and incorporated into plasma
membranes, gl ycosph i ngol
i
p i ds inhibit cell growth and modify
growth behavior (29, 43-53). However, in neoplastic cells, the
composition and pattern of occurrence of these molecules changes
dramatically. Glycol i p i ds in transformed cells are less complex
structurally (3). As a result, the cells lose some of their
78
previous cell surface recognition
-functions ( 8 , 9, 28, 54).
Kinders, £i .al
. , (55, 57, 58, 61) have previously described the
isolation and characterization of brain cell sur-face gl ycopep t i des
<BCSG) which inhibit cell growth and protein synthesis in normal
(56, 57), but not in trans-formed cells (59). Furthermore, BCSG has
been shown to bind to the cell surfaces of 3T3 mouse fibroblast
cells and LM cells containing exogenously incorporated GM
1
gangliosides (62). However, even though GM gangliosides are
1
capable of sensitizing the normally BCSG-re-f rac t i ve LM cells (60)
to the growth inhibitory effects of BCSG, they did not enhance the
binding o-f BCSG to the LM cell surfaces (62). Additionally,
Bascom, &± il.,<62) have shown that GM gangliosides could not
1
bind out the inhibitory activity o-f BCSG in experiments where GM
1
was preincubated with BCSG prior to the treatment of 3T3 target
cells.
The experiments described herein, were designed to determine
whether GM serves as a membrane receptor for BCSG. This
1
experimental study was part of an investigation of BCSG-GM
1
interaction in both direct binding assays to cells and to GM in
1
various 1
i
gand-recep tor binding systems. These parallel lines of
investigation were employed for two reasons. First, the
incorporation o-f exogenous gangliosides onto cell membranes
-from
the culture medium to observe binding of BCSG to GM is
1
complicated by the presence of serum. Since a number of growth
factors are present in serum and gangliosides have been shown to
79 -
interact with several of these growth factors (29) the effects of
gangl i osi de addition to ceils in culture to demonstrate BCSG
binding may have been obscured. Second, the orientation of GM in
1
1
i
gand-recep tor binding assays may not have permitted binding,
even by employing a variety of techniques which permit different
orientations of the GM molecule to make it accesible for bindino
1
by BCSG. The results obtained using GM in liposome, TLC, and
1
plastic adsorption systems are described here.
EXPERIMENTAL PROCEDURES
MATERIALS
BRAIN CELL SURFACE GLYCOPEPTI DES (BCSG)
The growth inhibitory gl ycopep t i des were provided by Dr. T. C.
Johnson '.Division of Biology, Kansas State University, Manhattan,
KS) (55, 61 , 62)
GANGLIGISIDES
6M and Bovine Brain Gancil i os i des <BB6) were obtained from
1
Supelco Chemical Company, Inc., Houston, TX . They were determined
by thin layer chromatography (TLC) and gas liquid chromatography
(GLC) to be 98:; pure and used without further purification.
Tritium-labeled gangl iosides were prepared according to the method
3
prescribed by Schwarzman (63). NaB H was obtained from New
4
England Nuclear, Boston, MA.
80 -
CHOLERA TOXIN
Cholera toxin -from yjLbcLo zh£±££Jl£ was purchased from two
sources: CI) Sigma Chemical Company, St. Louis, MO; and <2)
Schwarz Mann Chemical Company, Cambridge, MA. Rad i o i od
i
nated
cholera toxin was prepared as described by Cuatrecasas <44).
125
Iodine, sodium-tree carrier was obtained
-from New England
Nuclear, Boston, Massachusetts.
METHODS
THIN LAYER CHROMATOGRAPHY <TLC) BINDING ASSAr
The binding of cholera toxin to @M ganql i os i des can be detected
125 1
by autoradiography. I-cholera toxin wil bind to GM on silica
1
gel TLC plates after thin layer chromatography o-f the
ganglioside. The technique used in this assay was essentially
identical to that of Magnan i
, e.t al.,(47). This procedure is
summarized in Figure 7.
LIPOSOME BINDING ASSAYS
LIPOSOME PREPARATION
Unilamellar liposomes were prepared from egg phosphatidylcholine
CEPC), cholesterol, and GM to a f;nal mole to mole ratio of
1
70:30:10. Liposome constituents were mixed well, dried under N
,
and resuspended in 2.0 ml of buffer (20 mtl TRIS, . 1 5mU saline,
1 .OX Cw/u) albumin, pH 7.4;. The suspension was sonicated until no
81
further clearing was noted and the solution was opalescent <65).
An additional 5.0 ml of buffer was added post-son i cat i on to bring
the final volume of the suspension to 7.0 ml (a -final phospholipid
concentration - l.OmtJ. Unilamellar liposomes were stored in the
o
•freezer at C until used.
Multilamellar liposomes were prepared as described by Aloj, *i
al., (66). Dipalmi tylphosphat idvlchol me (DPPC), cholesterol, and
GM were combined in a molar ration o-f 2:1:0.2 as described by
1
Aloj, s± ^J.
. ,
(66). This procedure was a modi -f i cat i on of an
earlier protocol set forth by Kinsley, £_t ^1 . , (67) DPPC,
cholesterol and GM
,
were dissolved in 2:1 ch 1 oro-f orm, me thanoi
,
and combined in a 2:1:0.2 molar ratio. The preparation was mixed
well, dried under a stream o-f N and -finally resuspended in a 16 x
2
150 mm teflon capped via! containing 2.0 ml buffer ( 20mtl TRIS, lmtt
EDTA, and 1.0X bovine serum albumin (BSA), pH 7.2). The vial was
o
rotated for 18-24 hours at 4 C. Five 3 mm diameter glass beads
were added to the vial and the suspension was vortexed for 5-10
minutes until the lipid suspension was homogeneous. These
multilamellar
1 i posomes were washed three times with buffer and
centrifuged at 7000 rpm for 10 minutes. The liposome pellet was
resuspended in 2.0 ml of buffer. Fifty microliter ( 50 ul)
aliquots of a 1:8 dilution of the final liposome solution were
employed in the filtration binding assay to be described.
LI SAND-RECEPTOR BINDING ASSAYS USING RECONSTITUTED MODEL
MEMBRANES
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CENTRIFUGAL ELUTION ASSAY EMPLOYING MINI- GEL FILTRATION COLUMNS
We have employed a modification of the gel -filtration column
method published by Fry, e.t al. , (70). The Sepharose 4B and
Sephadex G-200 (Sigma Chemical Company, St. Louis, MO) gel
minicolumns were prepared in a 1.0 ml plastic syringe tube which
were then placed in appropriately sized centrifuge tubes. The
minicolumns were centrifuged at low speed to remove the void
volumes. The liposomes are loaded onto the top of the columns,
allowed to absorb, and centrifuged a second time at a low g force
to complete the absorption process. The determination of the time
and the cen tr i f ugat i on speed required is dependent upon the amount
and the type of gel employed.
Unilamellar liposomes, prepared as described above, were
incubated on ice for 60-90 minutes with either 100,000 cpm (or
125 125
about 15 ng) of I-cholera toxin or I-BCSG. Binding was
allowed to proceed and interrupted at various time intervals. The
samples were loaded onto minicolumns and allowed to enter without
manipulation. Columns were spun at 100 rpm for 10 minutes to
complete absorption of liposomes to the columns and then at 10 00
rpm for five minutes. In the same collection tube, columns were
washed twice with 100 ul of buffer and centrifuged in the same
125
manner. The resulting eluate containinng I-ligand bound to the
unilamellar liposomes, was counted by gamma emission in a Packard
Multi-Prias gamma counter. This procedure is summarized in Figure
- 83
FILTRATION ASSAY FOR MULTILAMELLAR LIPOSOMES
125 125
Binding o-f I-cholera toxin and
-BOSS binding to
multilamellar liposome was assayed by the -filtration technique
previously described by Mu 1 1 i n , £± *X . , ( 21 ) and Am i r , £± a! .
.
(40) -for thyroid plasma membranes. Multilamellar liposomes,
prepared as described above, were incubated with 15 no of
125 125
I-cholera toxin or I-BCSG in a manner analogous to that
described by Fishman, e.i al., (.68) for the binding of
125
I-choleragen to liposomes. The binding reactions were stopped
after 60-90 minutes with 1.5 ml ice-cold buffer. To separate
125
unbound I-ligand samples were -filtered under vacuum through 25
mm Millipore EGWP -filters (0.2 urn) (Millipore Corporation,
Bed-ford, MASS) and washed twice with 1.0 ml bu-f-fer. Filters were
dried and placed in 12 X 75 mm test tubes. The amount o-f
125
I-ligand bound to the GM containing liposomes was determined
1
by gamma emission counted in a Packard Multi-Prias gamma counter.
This procedure is summarized in Figure ?.
GLYCOL I PI D ADSORPTION ASSAY
125
The binding o-f I-BCSG to plastic adsorbed GM gangliosides
1
was performed similarly to the protocal o-f Holmgren, e.1 il . , (43,
46). This procedure is summarized in -figure 10.
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Exgu.ua 2: Diagrammatic representation o-f the thin layer
chromatogrphy assay -for ligand binding to gangl i osi des.
Eiguce. S: Diagrammatic representation o-f the liposome
centri-fuga! elution assay o-f ligand binding to gangl i os i des.
Eiguce. 2: Diagrammatic representation o-f the liposome -filtration
assay o-f ligand binding to gangl iosides.
Ej-guta ID.: Diagrammatic representation o-f ligand binding to GM-1
gangl iosides adsorbed onto polystyrene plastic tubes.
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RESULTS AND DISCUSSION
To ascertain the role of the GM ganglioside as a growth
1
regulator o-f the effects o-f BCSG on cell growth, I studied the
direct binding the radi o i odi nated 1 i gand to thin layer
chromatographed GM . In initial experiments direct binding o-f
125 I
I-BCSG was observed a-fter autoradiography. Similar results
125
were obtained with the I-cholera toxin - GM 1 I gand-recep ton
1
positive control (Figure 11). Competitive binding experiments
125 125
performed between I-BCSG and I-cholera toxin demonstrated
that the growth inhibitor competed with cholera toxin -for binding
GM (Figure 12). Mod i -f i ca t i ons now employed in the pur i
-f i cat i on
process o-f BCSG (62), a 500-fold increase in purity o-f the
preparation o-f the growth inhibitor has been obtained and using
the same experimental procedures these brain pool preparations o-f
BCSG -failed to yield equivalent results. Thus, the bindino, of
125
I-BCSG to GM observed in the -first analyses o-f the TLC Binding
1
Assay was likely due to the heterogeneity o-f the earliest BCSG
preparations and that a "contaminating" molecular species bound to
GM .
1
The inability to demonstrate BCSG binding in the same system
lead to suggests that the orientation o-f GM on the TLC plates
1
does not to permit binding o-f BCSG. Furthermore, the binding
affinity of BCSG to GM may be so low that this system even though
1 125
suitable for demonstrating I-cholera toxin to GM
1
I
i
gand-recep tor interaction (47) cannot be employed in the same
- 90 -
capacity -for analyzing the interaction between BCSG and GM .
There-fore, other 1 i gand-recep tor binding assays were sought to
find the most e-f-fective means to examine the potential o-f GM as a
1
receptor -for BCSG.
Two addi
t
ional direct 1 i gand-recep tor binding techniques were
employed (with appropriate positive controls with cholera toxin)
to investigate whether GM in such systems could serve as a
125 1
, 25
receptor for I-BCSG. In liposome binding experiments, I -BCSG
was not observed to bind to GM incorporated into either
1
unilamellar or multilamellar liposomes. The presence or absence
o-f GM or cholesterol, the species of phosphatidylcholine, the
ratio o-f phospholipid to cholesterol to GM
,
and the means by
125 1
which bound versus -free I-ligandwere separated (that is,
mini-gel column -filtration or vacuum
-filtration) had no e-f-fect on
the results. (Tables 3-11 and Figures 13, 14) The experimental
3
recovery o-f liposomes containing H-chol esterol was approximately
39.3^ regardless o-f the liposome sample '50-200 ul) (Tables 12 and
13) (This value is comparable to that obtained by Fishman, it ii.,
>-.63> who reported the recovery ot liposomes by similar techniques
as 87, 6'/..1 .
In the third 1 i gand-recep tor binding assay employed to
125
demonstrate GM serves a receptor
-function -for BCSG, I-BCSG did
1
not bind to GM adsorbed onto polystyrene tubes (Table 14).
1
Quantitation o-f gangliside adsorption was determined by
3
incorporating 10 nmoles o-f H-GM into the total 60 nmoles of
1
- 91
gangl ioside used -for the adsorption procedure. Approximately 25X
3
o-f the H-GM was adsorbed at 18-24 hours and this amount remained
1
unchanged for 72 hours after adsorption (Data not shown). Thus
each reaction vessel contained about 15 nanomoles of GM (or 2 X
12
1
10 molecules of GM )
.
The addition of 0.01X Tween 20 to the
1
buffer did not cause solubilization of the adhered gangl i os i des
,
even at extended periods of incubation (Data not shown).
Furthermore, the polystyrene-adsorbed GM retained its specific
1
1 i gand-bi ndi ng properties as demonstrated by its ability to bind
125
I-cholera toxin. It has been reported (46) that the attachment
of the GM 9anglioside to polystyrene plastic exhibits a
1
log-linear relationship between the amount of ""' sound and time.
1
Holmgren, a± al., (45) further demonstrated a similar linear
125
relationship between the amount of I
—
cholera toxin able to
bind to plastic-adsorbed GM . The applicability of this binding
1
system has been extended to viruses and gangl ioside receotor
analyses (45, 46). However , we could not demonstrate that
125
I-BCSG binds to GM using this assay.
1
From these data it was concluded that GM in direct
125
1 i gand-recep tor binding assays did not bind to I-BCSG (Data
summarized in Table 15). These results correlate directly with
data obtained in our cell binding experiments (See Chapter 3, and
ref. 62). These analyses imply that GM does not serve as a high
1
affinity membrane receptor for the growth inhibitory
gl ycopep t i des
.
92 -
It has been demonstrated that various growth -factors are
a-f-fected by the presence o-f gangliosides (29, 69). The
incorporation o-f exogenous GM gangliosides has been demonstrated
1
to inhibit the e-f-fects o-f platelet-derived growth -factor <PDGF)
and epidermal growth factor (EGF), but in neither case has PDGF or
EGF been demonstrated to bind to the gangliosides. (70) On the
other hand, the GM ganglioside has been shown to enhance the
3
sensitivity oi cells to -fibroblast growth -factor <FGF). However,
FGF has also does not bind to GM . Furthermore, GM has been shown
3 1
to modulate the PDGF receptor by altering its ability to be
phospnoryl ated (69). It is possible we may be analyzing a system
analogous has been described -for these other growth -factors.
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Ej-guce. ill 125 I - Ligand Binding to GM-1 Gangliosides
Chroma tographed on Thin Layer Chromatography (TLC) plates and
visualized by autoradiography.
40 nanomoles of GM-1 ganglioside were chromatographed on Kodak
Eastman silica gel TLC plates in a solvent system composed of
chl orof orm/me thanol /magnes i um chloride/ammonium hydroxide
(60:35:7.5:3)
.
Once the solvent had evaporated
-from the plates,
direct binding o-f 125 I - Cholera Toxin or 125 I - BCSG was
performed on ice in a TLC binding buffer containing: O.lSmtlNaCl;
lOmfclNa HPO
; and 1.0X polyvinyl pyrrol i done at pH 7.4. After
2 4
incubation the strips from the plates were washed twice with cold
buffer, dried, and au torad i ographed. Figure 10 illustrates a
typical autoradi ographed TLC plate after direct binding of 125 I -
cholera tox i n
.
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Eigiic.fi. 12: Competitive Binding For GM-1 By 125 I - Cholera Toxin
and Growth-Inhibitory Brain Cell Surface SI ycopep t i des on Thin
Layer Chromatography Plates.
40 nanomoles of GM-1 ganglioside were chromatographed on Kodac
Eastman silica gel TLC plates in a solvent system o-f
chl orof orm/methanol/magnesi um chloride/ammonium hydroxide
(60:35:7.5:3). After the solvent had evaporated from the plates
and the plates prepared for the direct binding of 125 I - Cholera
Toxin to GM-1, incubation buffers of the appropriate tubes were
prepared containing increasing concentrations of the Brain Cell
Surface Gl ycopep t i des. Addition of up to 1.75 ug/'ml BCSG to the
tubes was able to decrease the amount of 125 I - Cholera Toxin to
bind to the GM-1 on the TLC plates by over 2000 counts per minute
bound above background.
96 -
10.
o
COMPETITIVE BINDING FOR GM. ON TLC PLATES
BCSG lug/ml)
XahXe 8: Specific Binding of 125 I - Cholera Toxin and
125 I - Growth-Inhibitory Brain Cell Surface Gl ycopep t i des
to Unilamellar Liposomes via the Liposome Centrifugal Elution
Assay with Sepharose 4B Syringe Minicolumns.
125 I - Ligand Liposome cpm 125 I % Control Total %
Composition Bound Eluate Bound
EPC/CHOL 9617
EPC/CHOL/BBG 21213
EPC/CHOL/ 29783
SULFATIDES
EPC/CHOL 661
EPC/CHOL/BBG 1 122
EPC/CHOL/ 90 5
SULFATIDES
125 I - 100% 5%
chol era
toxin 87*/ 11%
81% 15. 5%
125 I - 100% 2.97.
BCSG
92% 4 . 9%
94%% 3 . 9%
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Iahlfi. 2: Time dependence o-f 125 I - Growth-Inhibitory Brain Cell
Sur-face Gl ycopep t i des Binding to Unilamellar Liposomes uia the
Liposome Centrifugal Elution Assay Employing Sepharose 4B Syringe
Mi n i col umns
.
Length o-f Liposome cpm 125 I Total cpm
Incubation Composition Eluted Bound
(minutes) C/. 125 I Assay Assay
recovered) #1 #2
EPC/CHOL 15.571 3250 4691
(70:30) (74. 2/.')
30 17257 2902 4596
(82.2/:)
40 17510 3675 4376
(33.4^.)
EPC/CHOL/BBG 14609 2343 3739
(70:30:5) (69.6X)
30 17558 3795 4729
(83.7/;)
60 16615 1959 4731
( 79 . 27.
)
??
Exauce. 13: Time Dependence o-f 125 I - Cholera Toxin Binding to
Egg Phosphatidylcholine \EPC> and Cholesterol (CHOL) Unilamellar
Liposomes With and Without Incorporated GM-1 Gangliosides via the
Liposome Centri-fugal Elution Assay Employing Sephadex G-200
Syringe Minicolumns.
EPC/CHOL <70:30, mole/mole> and EPC/CHOL/GM-1 < 70: 30: 10,
mole/mole) unilamellar liposomes were prepared as described in the
experimental procedures. These liposomes were incubated in PBS
with 100,000 cpm 125 I - cholera toxin -for 15, 30, and 60
minutes. Unbound 125 I - cholera toxin was separated from that
bound to the liposomes by cen tr i -f ug i ng at a low g -force UQOOrpm)
through 1.0 ml sepharose 4B mini - gel -filtration columns < 70 ) .
The open circles represent the amount o-f 125 I - cholera toxin
bound to EPC/CHOL liposomes and the closed circles represent the
amount of 125 I - cholera toxin bound to EPC/CHOL/GM-1 liposomes.
100 -
Q
Z
o
o
O
<
\
Q
Z
o
£
a
60
TIME (minutes)
labia 10.: Specific Binding o-f 125 I - Cholera Toxin to
Unilamellar Liposomes uia the Liposome Centri-fugal Elution
Assay Employing Sephadex G-200 Syringe Minicolumns.
Liposome cpm 125 I - V. Control Total V.
Composition Cholera Toxin Bound Bound
Bound
Exper imen t 1
:
EPC 15,350 100% 7.9V.
C 1 00)
EPC/CHOL 16,138 36. TA 10. 2Y.
< 70 : 30 '•>
EPC/CHOL/BBG 26,574 122% \6. TA
(70:30:55
Exper imen t 2
:
DPPC/CHOL 232 10 0% 4
. 8%
( 70:301
DPPC/CHOL/GM-1 543 200% 21.8%
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Labia 11: 125 I - Growth-Inhibitory Brain Cell Surface
Gl ycopept i des Binding to Multilamellar Liposomes Containing
Bouine Brain Gangl i osi des. Separation o-f Bound versus Free
125 I - BCSG via the Liposome Filtration Assay.
Liposome cpm 125 I - BCSG Total V.
Composition Bound Bound
DPPC/CHOL 235 4 . ?•/.
(70:30)
DPPC/CHOL/BBG 210 4 . 27.
(70:30:5)
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EiQUta 14: Time Dependence o-f 125 I - Cholera Toxin and 125 I -
Growth-Inhibitory Brain Cell Sur-face Ql ycopep t i des (BCSG) Binding
to Di palmi toyl phosphat i dyl chol i ne (DPPC) Cholesterol (CHOL) and
GM-1 Gangliosides (70:30:5) Multilamellar Liposomes via the
Liposome Filtration Assay.
DPPC/CHOL/GM-1 (70:30:5, mole/mole.) and DPPC/CHOL (70:30,
mole/mole) unilamellar liposomes were prepared as described in the
experimental procedures. These liposomes were incubated in bu-f-fer
(20 mM TRIS, 0.15 mM EDTA , 1 . 0Y. BSA
,
pH 7.2) containing either
100,000 cpm 125 I -cholera toxin or 100,000 cpm 125 I - BC5G -for
30 and 60 minutes. Unbound 125 I - ligand was separated -from that
bound to the 1 iposomes by centri-fuging at a low g -force (1000 rpm)
through 1.0 ml sephadex G-200 mini - gel -filtration columns (70).
The amount o-f 125 I - ligand bound to DPPC/CHOL liposomes was
subtracted -from that bound to DPPC/CHOL/GM-1 liposomes as
background. The closed circles represent the amount o-f 125 I -
cholera toxin bound to the GM-1 in the DPPC/CHOL/GM-1 liposomes
and the closed squares represent the amount o-f 1 25 I - BCSG bound
to the GM-1 in similarly prepared DPPC/CHOL/GM-1 liposomes.
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30 60
TIME (minute*)
Iahla. 12: Percent Recovery of 3 H - Labeled Liposomes
Through Sepharose Minicolumns via the Liposome Centrifugal
Elution Assay.
Minicolumn Type of Syringe Length of V. 3 H - Liposomes
Bed Volume Plug Employed 3pm Recovered
icz> (minutes) (in 1200 ul)
4B Separose:
0-73 Cellophane 3 70 . 4X
0.60 Cellophane 1 77.9"/
0.75 Spun Glass 3 76.6V.
0.65 Spun Glass 1 83
.
2V. *
6B Sepharose
:
0.84 Cellophane 3 77.2/i
0.77 Cellophane 1 79.9V.
0.78 Spun Glass 3 79.4V.
0.76 Spun Glass 1 81.6X
* = Syringe Minicolumn Method Employed.
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labia 13: Recovery o-f 3 H - Liposomes versus 125 I -
Cholera Toxin Through Sephadex G-200 Minicolumns —
Determination o-f Retention Times o-f Liposomes versus Free
125 I - Ligand.
Substance '/, cpm Recovered
Recovered Eluate 200 microliter wash Total V.
**1 #2 #3 #4 #5 Recovered
3 H - 55.0 27.0 5.6 1.8 1.2 1.0
Liposomes < 55 . ) (82.0) (37.6) (89.4) (90.6) (91.6) 91,6/.
1 25 I - 7.0 10.3 14.0 14.3 12.4 10.5
:-!Ol«ra (7.0) (17.3) (31.3) (45.6) (58.0) (68.5) 68. 5V.
Tox i n
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libit 14: Binding o-f 125 I - Growth-Inhibitory Brain C»11
Surface G1 ycopep t
i
des to GM-1 Gangliosides Adsorbed onto
Polystyrene Tubes.
Rad i o i od
i
nated Nanomoles cpm 125 I - Ligand Bound
Ligand o-f GM-1 Length o-f Incubation
Gangl loside < Hours)
0.0 2.0
125 I - BCSG 0.0 203 +/- 237 217 +/- 174
(0.51V:> (0.4955)
0.2 226 +/- 172 300 /- 225
<0.535O '.0.6?y.)
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Eiguca 15: Time Dependence o-f Binding o-f 125 I - Cholera Toxin
to Bovine Brain Gangl iosides (BBS) Adsorbed onto Polystyrene
PI ast i c Test Tubes.
60 nanomoles o-f BBG (containing approximately 40X GM-1
gangl i osi des) were adsorbed onto 12 X 75 mm Falcon polystyrene
tubes (Becton and Dickinson;' by the ethanol evaporation method of
Holmgren, e.± al., (.45, 46; . In a 200 ul total volume, composed o-f
bu-f-fer (20 mM TRIS, 0.15 mM EDTA. 0.01X Tween 20, pH 7.2) and
50,000 cpm (about 7.5 ng) o-f 125 I - cholera toxin, the adsorbed
gangl iosides were incubated with 125 I - 1 i gand -for 15, 30, and 60
minutes at room temperature. Unbound 125 I - 1
i
gand was aspirated
from the tubes and the tubes were washed with 200 ul o-f but -fen.
The amount o-f 125 I - cholera toxin bound to polystyrene tubes
containing no gangl iosides and treated in a similar manner as
tubes with adsorbed gangl i os i des were subtracted -from the amount
o-f 125 I -cholera toxin bound to the plastic adsorbed gangl iosides
as background.
- 109
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labia. 15: Data Summary o-f 125 I - Ligand Binding to
the GM-1 Gangl ioside via Various In ullco Binding Assays.
Assay Method 125 I - Cholera 125 I - BCSG
Tox i n
TLC Bi ndi ng Assay
125 ! - BCSG
Competition Between
Cold BCSG and 125 I -
Choi era Tox i n
Liposome Binding Systems
Cen tr i f ugal El u t i on
Assay +
Filtration Assay +
Glycol ipid Adsorption Assay
- Ill
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ABSTRACT
As plasma membrane components of many cells, gangliosides have
been shown to serve as membrane receptors for various biologically
active substances. Furthermore, gangliosides have been
demonstrated to modulate the effects of various growth factors.
Even though gangliosides Are capable of modulating the effects of
growth factors such as platelet-derived growth factor and
epidermal growth factor, they do not bind to these
growth-affecting molecules. Ue have examined the interaction of
gangliosides with molecules which inhibit the growth of cultured
an i mal eel Is.
Growth-inhibitory gl ycopep t i des have been purified and
characterized from bovine cerebral cortex cells. These
gl ycopep t i des are capable of inhibiting both protein synthesis and
cell division in normal cells. Mouse LM cells have no detectable
gangliosides within their plasma membranes and are refractory to
the inhibitor. Incubation of exogenous GM gangliosides with the
1
LM cells confers sensitivity to the inhibitor upon the cells. The
sensitization of cells to the inhibitory action of the
gl ycopep t i des i mp 1 ies that GM may act as a membrane receptor or
1
receptor modulator for these molecules. Elucidation of the
functional role played by GM in this growth-regulatory process
1
was analyzed by both In u±un and In jjj.-i.co 1 i gand-recep tor binding
assays to detect binding of inhibitor to gangliosides. In cell
binding assays, it was shown that incubation of exogenous
gangliosides with these cells, though capable of sensitizing them
to the growth inhibitor, did not result in an increase in binding
of the inhibitor to the cells. Furthermore, various la UJLtCA
1 i gand-recep tor binding assays were performed using the cholera
toxin-GM ligand receptor model. These studies also demonstrated
1
the inability o-f the growth inhibitor to bind to QM
gangl i osi des. In addition, protease digestion o-f cells able to
bind the growth inhibitor significantly decreased inhibitor
binding. This implies that a membrane protein was involved in the
growth inhibitor-membrane interaction. Neuraminidase treatment of
the same cells was able to enhance slightly the binding of the
growth-inhibitory gl ycopep t i des to the cells apparently from an
increase in membrane GM
. These data suggest that membrane
1
gangl ioside GM functions in the modulation of the actual membrane
1
receptor for the growth inhibitory gl ycopep t i des
.
Hypotheses explaining the molecular mechanism of GM as a
1
modulator of membrane recep tor < s> are speculative at best.
Progress in the elucidation of the role of gang! i o i s i des as
membrane receptors has been achieved through studies of the
interaction of the en tero toxin of Uj hr j p - b nlirja with the GM
1
gangl ioside. As a lect in-like molecule, cholera toxin has proved
to be a useful investigative tool towards the understanding of
membrane structure and receptor mobility as well as receptor
function. GM gangl ioside has been demonstrated to be fre-lv
1
mobile within the lipid bi layer. Thus, GM is capable of
1
interacting with other membrane components such as membrane
proteins (receptors) and lipids. Specifically, when GM is
1
incorporated into model membrane lipid systems, the interaction o-f
GM with the phosphol i p i d< s) results in an increase in membrane
1
order. We examined the e-f-fects o-f 1 i gand-recep tor interaction
between GM and cholera toxin to elucidate the
-functional and
1
behavioral role o-f GM as a membrane receptor. By employing
fluorescence polarization and light scattering, we were able to
detect 1 ec t i n-i nduced agglutination o-f liposomes containing GM
.
In addition, glycol ipid clustering events within these model
membranes resulted in a disordering o-f the membrane lipids. Such
events can significantly alter membrane dynamics which in turn can
lead to changes in membrane permeability or cell surface
func t i on
.
